ID   PDE5A_MOUSE             Reviewed;         865 AA.
AC   Q8CG03; Q0VBW0;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   07-APR-2021, entry version 136.
DE   RecName: Full=cGMP-specific 3',5'-cyclic phosphodiesterase;
DE            EC=3.1.4.35 {ECO:0000250|UniProtKB:O76074};
DE   AltName: Full=cGMP-binding cGMP-specific phosphodiesterase;
DE            Short=CGB-PDE;
GN   Name=Pde5a; Synonyms=Pde5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Burns F., Sonnenburg W.K., Rybalkin S.D., Beavo J.A.;
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Plays a role in signal transduction by regulating the
CC       intracellular concentration of cyclic nucleotides. This
CC       phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP.
CC       Specifically regulates nitric-oxide-generated cGMP.
CC       {ECO:0000250|UniProtKB:O76074}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP + H2O = GMP + H(+); Xref=Rhea:RHEA:16957,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57746,
CC         ChEBI:CHEBI:58115; EC=3.1.4.35;
CC         Evidence={ECO:0000250|UniProtKB:O76074};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:O76074};
CC       Note=Binds 1 Zn(2+) ion per subunit. Binds 2 divalent metal cations per
CC       subunit: site 1 preferentially binds zinc, while site 2 has a
CC       preference for magnesium. Tightly binds zinc.
CC       {ECO:0000250|UniProtKB:O76074};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O76074};
CC       Note=Binds 1 Mg(2+) ions per subunit. Binds 2 divalent metal cations
CC       per subunit: site 1 preferentially binds zinc, while site 2 has a
CC       preference for magnesium. Binds magnesium less tightly than zinc.
CC       {ECO:0000250|UniProtKB:O76074};
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from
CC       3',5'-cyclic GMP: step 1/1.
CC   -!- DOMAIN: Composed of a C-terminal catalytic domain containing two
CC       putative divalent metal sites and an N-terminal regulatory domain which
CC       contains two homologous allosteric cGMP-binding regions, A and B.
CC   -!- PTM: Phosphorylation is regulated by binding of cGMP to the two
CC       allosteric sites. Phosphorylation by PRKG1 leads to its activation.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF541937; AAN17330.1; -; mRNA.
DR   EMBL; CH466532; EDL12317.1; -; Genomic_DNA.
DR   EMBL; BC119137; AAI19138.1; -; mRNA.
DR   EMBL; BC120486; AAI20487.1; -; mRNA.
DR   CCDS; CCDS17812.1; -.
DR   RefSeq; NP_700471.2; NM_153422.2.
DR   PDB; 2K31; NMR; -; A=154-320.
DR   PDBsum; 2K31; -.
DR   SMR; Q8CG03; -.
DR   BioGRID; 232382; 5.
DR   IntAct; Q8CG03; 2.
DR   MINT; Q8CG03; -.
DR   STRING; 10090.ENSMUSP00000069011; -.
DR   iPTMnet; Q8CG03; -.
DR   PhosphoSitePlus; Q8CG03; -.
DR   jPOST; Q8CG03; -.
DR   MaxQB; Q8CG03; -.
DR   PaxDb; Q8CG03; -.
DR   PeptideAtlas; Q8CG03; -.
DR   PRIDE; Q8CG03; -.
DR   ProteomicsDB; 301780; -.
DR   Antibodypedia; 1386; 168 antibodies.
DR   Ensembl; ENSMUST00000066728; ENSMUSP00000069011; ENSMUSG00000053965.
DR   GeneID; 242202; -.
DR   KEGG; mmu:242202; -.
DR   UCSC; uc008ret.2; mouse.
DR   CTD; 8654; -.
DR   MGI; MGI:2651499; Pde5a.
DR   eggNOG; KOG3689; Eukaryota.
DR   GeneTree; ENSGT00940000155475; -.
DR   InParanoid; Q8CG03; -.
DR   OrthoDB; 904682at2759; -.
DR   TreeFam; TF316499; -.
DR   BRENDA; 3.1.4.35; 3474.
DR   Reactome; R-MMU-418457; cGMP effects.
DR   UniPathway; UPA00763; UER00748.
DR   BioGRID-ORCS; 242202; 3 hits in 52 CRISPR screens.
DR   ChiTaRS; Pde5a; mouse.
DR   EvolutionaryTrace; Q8CG03; -.
DR   PRO; PR:Q8CG03; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; Q8CG03; protein.
DR   Bgee; ENSMUSG00000053965; Expressed in lung and 256 other tissues.
DR   Genevisible; Q8CG03; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; ISO:MGI.
DR   GO; GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; IMP:MGI.
DR   GO; GO:0030553; F:cGMP binding; IDA:MGI.
DR   GO; GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046069; P:cGMP catabolic process; IDA:MGI.
DR   GO; GO:0046068; P:cGMP metabolic process; IMP:MGI.
DR   GO; GO:0055118; P:negative regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:MGI.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IMP:BHF-UCL.
DR   GO; GO:0002678; P:positive regulation of chronic inflammatory response; ISO:MGI.
DR   GO; GO:0045745; P:positive regulation of G protein-coupled receptor signaling pathway; IC:BHF-UCL.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IMP:BHF-UCL.
DR   GO; GO:0060282; P:positive regulation of oocyte development; IMP:MGI.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; ISO:MGI.
DR   GO; GO:0010749; P:regulation of nitric oxide mediated signal transduction; IGI:MGI.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; ISO:MGI.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; IMP:BHF-UCL.
DR   GO; GO:0007614; P:short-term memory; ISO:MGI.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd00077; HDc; 1.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF-like_dom_sf.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR036971; PDEase_catalytic_dom_sf.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF01590; GAF; 2.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 2.
DR   SMART; SM00471; HDc; 1.
DR   PROSITE; PS00126; PDEASE_I_1; 1.
DR   PROSITE; PS51845; PDEASE_I_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; cGMP; cGMP-binding; Hydrolase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Zinc.
FT   CHAIN           1..865
FT                   /note="cGMP-specific 3',5'-cyclic phosphodiesterase"
FT                   /id="PRO_0000198824"
FT   DOMAIN          154..304
FT                   /note="GAF 1"
FT   DOMAIN          336..493
FT                   /note="GAF 2"
FT   DOMAIN          526..850
FT                   /note="PDEase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   ACT_SITE        603
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   METAL           607
FT                   /note="Zinc; via tele nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:O76074"
FT   METAL           643
FT                   /note="Zinc; via tele nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:O76074"
FT   METAL           644
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:O76074"
FT   METAL           644
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250|UniProtKB:O76074"
FT   METAL           754
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250|UniProtKB:O76074"
FT   BINDING         807
FT                   /note="3',5'-cGMP"
FT                   /evidence="ECO:0000250|UniProtKB:O76074"
FT   MOD_RES         92
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        176
FT                   /note="S -> T (in Ref. 1; AAN17330)"
FT                   /evidence="ECO:0000305"
FT   HELIX           158..166
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   TURN            167..171
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          173..183
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   TURN            184..186
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          187..197
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   TURN            204..206
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          207..209
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          212..214
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   TURN            215..217
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   HELIX           219..226
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          230..233
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          238..240
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   HELIX           245..249
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          256..263
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   TURN            264..266
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   STRAND          267..275
FT                   /evidence="ECO:0007744|PDB:2K31"
FT   HELIX           287..300
FT                   /evidence="ECO:0007744|PDB:2K31"
SQ   SEQUENCE   865 AA;  98407 MW;  BADD21CC6B62045E CRC64;
     MERAGPNSVR SQQQRDPDWV EAWLDDHRDF TFSYFIRKAT RDMVNAWFSE RVHNIPVCKE
     GIRAHTESCS CSLQQSPHAD NTTPGAPARK ISASEFDRPL RPIVVKDSEG TVSFLSDSGK
     KEQMPLTPPR FDSDEGDQCS RLLELVKDIS SHLDVTALCH KIFLHIHGLI SADRYSLFLV
     CEDSSKDKFL ISRLFDVAEG STLEEASNNC IRLEWNKGIV GHVAAFGEPL NIKDAYEDPR
     FNAEVDQITG YKTQSILCMP IKNHREEVVG VAQAINKKSG NGGTFTEKDE KDFAAYLAFC
     GIVLHNAQLY ETSLLENKRN QVLLDLASLI FEEQQSLEVI LKKIAATIIS FMQVQKCTIF
     IVDEDCPDSF SRVFHMECEE VGKPSDPLTR EQDANKINYM YAQYVKNTME PLNIPDVTKD
     KRFPWTNENM GHVNTPCIGS LLCTPIKNGK KNKVIGVCQL VNKMEENTGK IKAFNQNDEQ
     FLEAFVIFCG LGIQNTQMYE AVERAMAKQM VTLEVLSYHA SAAEEETREL QALSAAVVPS
     AQTLKITDFS FSDFELSDLE TALCTIRMFT DLNLVQNFQM KHEVLCRWIL SVKKNYRKNV
     AYHNWRHAFN TAQCMFAALK AGKIQNKLTD LETLALLIAA LSHDLDHRGV NNSYIQRSEH
     PLAQLYCHSI MEHHHFDQCL MILNSPGNQI LSGLSIDEYK TTLKIIKQAI LATDLALYIK
     RRGEFFELIR KNQFSFEDPL QKELFLAMLM TACDLSAITK PWPIQQRIAE LVAAEFFDQG
     DRERKELNME PADLMNREKK NKIPSMQVGF IDAICLQLYE ALTHVSEDCL PLLDGCRKNR
     QKWQALAEQQ EKMLLNGESS QGKRD
//
